600267 海正药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,644,6642,184,0941,456,6372,152,1411,758,968
投资活动产生之现金流量净额(198,673)(290,361)(292,674)(665,185)(515,728)
筹资活动产生之现金流量净额(1,243,627)(2,036,945)(1,004,207)(1,505,405)(2,074,013)
汇率变动对现金及现金等价物的影响2313,4744,7186,526(600)
现金及现金等价物净增加/(减少)202,595(139,738)164,474(11,922)(831,373)
期初现金及现金等价物余额1,189,8841,329,6231,165,1491,177,0712,008,444
期末现金及现金等价物余额1,392,4791,189,8841,329,6231,165,1491,177,071